NCT05104749

Homeopathic Treatment of Post-acute COVID-19 Syndrome

Homeopathic Treatment of Post-acute COVID-19 Syndrome- A Pilot Randomized Controlled Trial

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 77 (actual)
• Sponsor: Southwest College of Naturopathic Medicine · Academic / Other
• Sex: All
• Age: 18 Years – 64 Years
• Healthy volunteers: Not accepted

Summary

To determine whether an individually prescribed homeopathic medicine has an effect greater than a placebo and is a viable treatment option to improve fatigue and quality of life for patients suffering from the symptoms of Post-acute COVID-19 Syndrome. The researchers hope to achieve this goal by conducting a clinical trial that is scientifically rigorous and clinically relevant. Expected results of this pilot study will be to obtain sufficient experience and preliminary feasibility data to justify a larger clinical trial of this hypothesis.

Detailed description

The researchers objectives for the study are to: 1) identify efficient means of recruiting subjects, 2) test and refine the initial study design and treatment protocol, 3) evaluate the instruments for assessing treatment outcomes, 4) estimate sample sizes that will be required in the full-scale trial, 5) determine which homeopathic medicines are most often prescribed for this syndrome, and 6) determine whether there is a measurable effect size difference or positive trend in reduction of symptoms in patients treated with homeopathy.

Conditions

• Post-acute Covid-19 Syndrome

Interventions

Type	Name	Description
DRUG	Homeopathic Medication	Homeopathic medicines are prepared according to standardized methods as specified by the Homeopathic Pharmacopoeia of the United States (HPUS), which was mandated by Congress to regulate the manufacture of homeopathic medicines as part of the Food, Drug, and Cosmetics Act of 1939. All homeopathic medicines prescribed in this study must be found in the HPUS. For a complete list of homeopathic medicines, contact the researchers.
OTHER	Placebo	Inert lactose pellets

Timeline

• Start date: 2021-09-15
• Primary completion: 2022-04-22
• Completion: 2022-04-22
• First posted: 2021-11-03
• Last updated: 2023-11-22
• Results posted: 2023-11-22

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study